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Abstract.  The epidermal growth factor receptor 
(EGF-R) of human A431  cells bears an antigenic de- 
terminant that is closely related to the human blood 
group A  carbohydrate structure.  Labeling studies with 
blood group A  reactive anti-EGF-R monoclonal anti- 
bodies and various lectins revealed that A431  cultures 
are heterogeneous with respect to blood group A  ex- 
pression.  We have isolated clonal variants of these 
cells that either express (A431A  ÷ cells) or complete- 
ly lack (A431A- cells) the blood group A  specific 
N-acetyI-D-galactosamine (GalNAc) residue.  We show 
that this difference is due to the absence of a  UDP- 
GalNAc:Gal transferase activity in A431A- cells. 
Subsequently, we have compared EGF-R functioning 
in these cell lines.  Scatchard analysis of EGF-binding 
shows that in A431A- cells 6.3%  of the EGF-R be- 
longs to a  high affinity subclass (Kd =  0.4 nM) while 
in A431A  ÷ this subclass  represents only 3.2%  of the 
total receptor pool.  The elevated level of high affinity 
receptors  in A431A- cells is accompanied by a parallel 
increase in receptor protein- tyrosine kinase activity. 
In membrane preparations of A431A- cells, receptor 
autophosphorylation as well as phosphorylation of a 
tyrosine-containing peptide substrate is 2-3-fold 
higher as compared with A431A  ÷ cells.  In intact 
A431A- cells, the difference in receptor activity is 
measured as a 2-3-fold elevated level of receptor 
phosphorylation and a  2-3-fold higher abundance of 
phosphotyrosine in total cellular protein in A431A- 
cells. In addition, pS]methionine pulse-chase experi- 
ments showed a  ligand-independent increase in turn- 
over of EGF-R in A431A- cells: the receptor's half life 
in these cells is  10 h as compared with  17 h  in 
A431A  ÷ cells. Our results suggest a possible involve- 
ment of GalNAc residue(s) in determining EGF-R 
affinity, protein-tyrosine kinase activity and turnover in 
A431  cells.  Furthermore, our results indicate that high 
affinity EGF-R are the biologically active species with 
respect to protein-tyrosine kinase activity. 
T 
HE human epidermal growth factor receptor (EGF-R)' 
is  a  structurally well-characterized transmembrane 
glycoprotein (for reviews see references 3, 9, and 31). 
The intracellular part of the receptor has a strong homology 
with the avian v- erb-B oncogene (12) and contains a pro- 
tein-tyrosine kinase activity which is activated after EGF 
binding, leading to tyrosine phosphorylation of intracellular 
substrates as well as of the receptor itself (auto-phosphoryla- 
tion) (24).  The extracellular part contains the EGF-binding 
domain and is heavily glycosylated. It has been estimated 
that of the  12 potential N-linked glycosylation sites,  11  are 
1. Abbreviations used in this paper: EGE epidermal growth factor; EGF-R, 
epidermal  growth  factor  receptor;  GalNAc,  N-acetyI-D-galactosamine; 
DBA, dolichos Biflorus Agglutinin: UEA-I, Ulex Europaeus Agglutinin-l. 
occupied by carbohydrate structures, adding 30-40 kD to the 
molecular mass of the receptor (27). 
The  human epidermoid carcinoma A431 cell  line  is  a 
widely used model system in studies on the EGF-R, since it 
expresses an unusually high number of these receptors at its 
surface  (i.e.,  2-3  x  106/cell) (13). Using the  criteria  of 
Chiids et al. (5), at least six different receptor carbohydrate 
side chains display blood group relatedness in these ceils. A 
number of monoclonal antibodies directed against the EGF- 
R have been produced using membrane preparations of A431 
cells as immunogen. Most of these antibodies are directed 
against carbohydrate determinants which are reported to be 
present on other glycoproteins and glycolipids as well (11, 
28).  Measurements of binding of a number of the antibodies 
to receptor preparations in the presence of carbohydrates of 
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minants recognized are closely related to (or identical with) 
the human blood group A antigen (18, 19, 28). 
This apparently immunodominant determinant is charac- 
terized by a  terminal  N-acetyl-o-galactosamine (GalNAc) 
residue: 
GalNAcal- 3Gall31 -  3/4GIcNAc - 
2  2/4 
t 
1  1 
Fuca  Fucct. 
The role or influence of carbohydrates on receptor func- 
tion is by no means clear. Experiments with glycosylation in- 
hibitors have suggested that the receptor needs to be N-gly- 
cosylated for proper membrane insertion, EGF binding, and 
to serve as phosphate acceptor (35, 37). However, glycosyla- 
tion as such seems not sufficient and additional processing 
steps are required for proper receptor functioning (36). 
In the present study, we report the existence of A431 vari- 
ants  which are not recognized by blood group A  reactive 
anti-EGF-R monoclonal antibodies and lectins. These vari- 
ants comprise '~40% of the total number of cells in the pa- 
rental A431 line. We have subcloned the parental A431 cells 
and obtained a line that fully expressed (A431A ÷) and a line 
that completely lacked (A431A-) the A-antigen.  We show 
that the difference in blood group A  expression is due to 
the absence of UDP-GaINAc:Gal transferase activity from 
A431A- cells. 
Comparison of EGF-R properties in the clones showed 
that  in clone A431A-  there  is:  (a)  an elevated amount of 
high affinity EGF-R,  (b) enhanced EGF-R tyrosine kinase 
activity, and (c) a shorter half-life of the receptor as mea- 
sured  by  [3sS]methionine  pulse-chase  experiments.  These 
results suggest that alterations in the composition of  carbohy- 
drates shared by EGF-R and other plasma membrane compo- 
nents may influence EGF-R function by affecting the amount 
of high affinity EGF-binding sites.  Furthermore, our results 
indicate that an elevated high/low affinity EGF-R ratio leads 
to  enhanced  receptor protein-tyrosine kinase  activity and 
turnover, even in the absence of any added EGE 
Materials and Methods 
Cell Culture 
The parental A431 cell line as well as the clones derived from it were grown 
in DME supplemented with 7.5 % FCS and buffered with 44 mM NHCO3 
under a 7.5%  CO2 atmosphere. 
Anti-EGF-R Antibodies 
Monoclonal antibodies TI-5 and 29.1 were a gift ofJ. Schlessinger (Rehovot, 
Israel). Antibodies 2E9, 2D11, and 2G5 were obtained by immunizing mice 
with A431 plasma membrane vesicles, prepared as described (7). Antibod- 
ies were purified from ascites of hydridoma-injected mice by affinity chro- 
matography, at pH 8.1, on a protein A Sepharose column (Pharmacia, Woer- 
den, The Netherlands) as described (10). Antiserum 281-7 was prepared by 
immunizing rabbits with a synthetic EGF-R polypeptide sequence coupled 
to keyhole limpet haemocyanin (KLH). The sequence used was the same 
as described by Kris et al.  (26). 
Antibody-Glycolipid Recognition 
A431 cells grown to confluency on roller bottles (Falcon, Becton and Dick- 
inson Etten, Leur, The Netherlands) were scraped with a rubber policeman 
into PBS. The cells were pelleted at 2,000 g and lysed by sonication in water 
at 0°C. The sonicated ceils were extracted with 30 ml chloroform/methanol 
(2:1). The fluffy protein layer was reextracted with 30 ml chloroform/metha- 
nol/H20 (1:2:0.1).  The organic phases were combined and dried under N2. 
The dried  residue was taken up in 4  ml chloroform/methanol/H20 (30: 
60:8) and kept under a N2 atmosphere at -20°C. The isolated glycolipids 
were applied on aluminium foil high performance thin layer silicagel plates 
(Merck,  Amsterdam, The Netherlands),  10 ~tl for each lane.  Separation 
was by ascending chromatography in chloroform/methanol/water +0.02% 
CaCI22H20 (60:35:8).  After completion, the plates were dried under N_, 
and the lanes were separated using a pair of scissors. Before incubation with 
antibodies, the lanes were dipped in a  saturated solution of polyisobutyl- 
methaerylate  (Janssen,  Beerse,  Belgium)  in  n-butanol.  The  lanes were 
treated subsequently with (a) 10%  newborn calf serum in PBS (to saturate 
the lanes with protein), (b) a dilution of monoclonal antibody, (c) a  1,000- 
fold dilution of rabbit anti-mouse peroxidase (Nordic, Tilburg, The Nether- 
lands),  and  (d)  peroxidase  substrate  (3,3"  5'  5'-tetramethyl  benzidine) 
(Sigma Chemical Co., St. Louis, MO) in citrate buffer, pH 5.0, containing 
dioctyl sodium sulfosuccinate. 
Fluorescen  t Labeling of Cells 
For labeling experiments, cells were grown to near confluency on glass cov- 
erslips. Cells were fixed with 3% p-formaldehyde in PBS either before or 
after antibody/lectin incubations. Fluorescent-labeled lectins (E.  Y.,  San 
Mateo,  CA) were  used at 25  I.tg/ml.  For immunofluorescence, FITC- or 
rhodamine isothiocyanate-labeled rabbit  anti-mouse antibodies (Nordic) 
were used as secondary reagents. After labeling, cells were  mounted in 
polyvinyl alcohol (Moviol 7/88) containing medium and observed under a 
Zeiss microscope. 
Subcloning of  Cells 
For subcloning, A431 cells were seeded at one cell per three wells on 96- 
well tissue culture clusters (Costar, Badhoevedorp, The Netherlands). In- 
dividual colonies were removed from the plates by trypsinization, replated. 
and  screened  for  homogeneity by  immunofluorescence. This cycle  was 
repeated several times to obtain homogeneous clones. During the course of 
the experiments, clones were  repeatedly  checked for  variants by  immu- 
nofluorescence. 
Measurements of N-acetyl Galactosamine 
Transferase Activity 
Confluent A431 cells were scraped with a rubber policeman and spun down 
at 800 g. Cells were washed twice with PBS and lysed in a small volume 
of H20  containing 0.01 mM each  of the  following  protease  inhibitors: 
N-tosyl-L-phenyl alanyl  chloromethane  (TPCK),  N-tosyl-L-lysyl chloro- 
methane (TLCK), phenylmethylsulfonyl fluoride (PMSF),  and pepstatin. 
Lysis was enhanced by a Pjotter-Elvehjem system rotating at 1,200  rpm.  1 
nag of cellular protein was added to an incubation mixture containing 100 
mM MES (2[N-Morpholino] ethane sulfonic acid), adjusted to pH 6.7, with 
NaOH/20  mM  MnC1JI%  Triton  X-100,  7  /aM  uridine  dipbosphate 
[~4C]GalNAc  (60 Ci/mol sp act) and 0.255  mg A- porcine submaxillary 
mucin (PSM) as the acceptor substrate. Incubation was at 37°C for 1 h, after 
which period  the PSM  was precipitated  by addition of  1 ml  1%  phos- 
photungstic acid (PTA) in 0.5 M  HCI at 0°C. The precipitate was washed 
twice with PTA and once with methanol, and radioactivity was measured 
in a  Packard liquid scintillation counter. 
Preparation of Total Cell Lysates 
Total  cell lysates were prepared by scraping confluent cells with a  rubber 
policeman into PBS. Cells were collected by centrifugation at 500 g  for 3 
min and subsequently lysed by a 20-rain incubation at 0°C in buffer contain- 
ing  10  mM Tris/HCl,  pH  7.4,  150  mM  NaCI,  1%  Triton  X-IO0,  10% 
glycerol and 1 mM PMSF. Nuclei and debris were spun down at 12,000 g 
for 5 min at 4°C. The supernatants were collected and kept in small aliquots 
at  -70°C. 
Plasma Membrane Preparations 
Plasma membrane preparations  were  prepared  either  by  the  method of 
Thorn et al. (39), or by vesiculation of the cells as described by Cohen et 
al.  (7). 
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and Membrane Preparations 
Monolayers of cells grown on 24-well  tissue culture clusters (Costar) were 
washed three times with PBS. Mixtures of mI-labeled EGF (Amersham, 
Houten, The Netherlands, 100 laCi/p.g sp act) and unlabeled EGF (receptor 
grade, Collaborative Research, Waltham, MA) were prepared in DME con- 
taining 0.1%  BSA.  For determination of high affinity binding, cells were 
preincubated with 300 nM of antibody 2E9 for  180 rain at 20°C. 500 ~tl 
of mixture was added to the cells followed by an incubation for 120 rain at 
0°C. After this period, cells were washed five times with PBS, taken up in 
0.5 N NaOH, and cell associated radioactivity was measured in a gamma 
counter. Nonspecific binding was determined by adding an excess of unla- 
beled EGF. 
EGF binding to membrane preparations was determined by incubation 
of 50  p.g membrane protein with different amounts of [12~IlEGE Incuba- 
tion was for 30 min at 20°C. After this period, the membranes were col- 
lected  and  washed  by  vacuum  aspiration  on  cellulose  acetate  filters 
(Schleicher & Schuell, Hertogenbosch, The Netherlands, pore diameter 0.2 
tam).  The filters were dried and counted in a gamma counter. 
EGF-R 7);rosine Kinase Activity 
Measurements In Vitro 
EGF-R  preparations  (total  cell  lysates  or  plasma  membranes)  were  in- 
cubated with or without EGF for 10 min at 20°C. The phosphorylation reac- 
tion was started by adding a mixture containing 20 mM Hepes, pH 7.4,  2 
mM  MnCI.,,  10  mM p-nitrophenylphosphate (PNPP),  40  /aM  Na3VO4, 
0.01% BSA,  15  laM  ATP and  1 laCi [y-32PlATP (Amersham, UK, 3,000 
Ci/mmol sp. act.) in a final volume of 60 ~tl. The reaction was allowed to 
proceed for  10  rain on ice, and was subsequently stopped by boiling in 
Laemmli sample buffer for SDS-gel electrophoresis, or by application of 
the mixture to Whatmann 3-ram filters which were then soaked in a  10% 
TCA solution containing 10 mM Na4P_~O7 for determination of total endog- 
enous  membrane  32P-incorporation.  Phosphorylation  of  the  tyrosine- 
containing peptide angiotensin I was essentially the same, except the incuba- 
tion was in the presence of 0.2%  Nonidet P-40 (NP-40) and for 5  min at 
20°C. Phosphorylated membrane proteins were separated from the peptide 
by TCA precipitation. The phosphorylated peptide was collected by apply- 
ing the supernatant to phosphocellulose paper (Whatman P81) which was 
subsequently washed with 7.5  mM H3PO4. 
EGF-R and Total Cellular Phosphotyrosine 
Content in Intact Cells 
Cells  grown  to  subconfluency  (150,000  cells/cm  2)  on  35-mm  dishes 
(Costar) were labeled with 1 mCi/ml [32P]orthophosphate  (Amersham) in 
phosphate-free DME (Gibco Breda, The Netherlands, Pharmacia, Woer- 
don, The Netherlands) for  16 h. EGF (50 ng/ml) or buffer were added to 
the same medium for an additional 30 min. After this, cells were lysed in 
R1PA buffer (150 mM NaCl, 20 mM Tris/HCl, pH 8.0, l0 mM NaHEPO4, 
5  mM  EDTA,  O.1  mM  Na3VO4,  1%  NPJ,0,  1%  sodium desoxycholate, 
0.1% SDS,  1 mM PMSE  100 KIU ml Aprotinin). For receptor phospho- 
amino acid analysis, the receptor was precipitated using antiserum 281-7 and 
protein A-sepharose  beads (Pharmacia). The precipitate was applied to a lin- 
ear 5-15 % SDS-polyacrylamide gel. The receptor band was localized in the 
dried gel by autoradiography, cut out with a razor blade and homogenized 
in 50 mM NH4HCO3/0.2%  SDS/2% I~-mercaptoethanol.  After incubation 
for 5  min at  100°C  and  120  min at  20°C  the homogenate was spun at 
10,000 g for 2 min and the supernatant was collected. After addition of 20 
I.tg RNAse (Sigma Chemical Co.) and incubation for 15 min on ice, TCA 
was added to a final concentration of 12.5%.  The TCA precipitates were 
collected by centrifugation at 12,000 g for 5 min and washed once with pure 
ethanol. The pellets were dried under a stream of N2.  By this procedure, 
",,70%  of the counts present in the gel were recovered as measured by 
Cerenkov radiation. The pellets were resuspended in a small volume of for- 
mic acid and used for both phosphoaminoacid analysis and tryptic phos- 
phopeptide mapping. Total cellular protein was extracted from RIPA lysates 
of parallel series of dishes by phenol extraction as described by Hunter and 
Sefton (22). Isolated receptor protein was hydrolysed in 6 M HC1 at II0°C 
for 60 min. Total cellular protein was hydrolyzed in 6 M HCI at  IlO°C for 
120 mins. The hydrolysed samples were applied to plastic foil thin layer cel- 
lulose plates (Merck, 5577) together with 60 ng each of unlabeled P-SER, 
P-THR, and P-TYR.  Two-dimensional electrophoresis, at pH  1.9, and pH 
3.5, were as described by Cooper and Hunter (8).  Phosphoamino acids were 
detected by spraying with 0.25%  ninhydrin in acetone. After autoradiogra- 
phy the phosphoamino spots were cut from the plate using a pair of scissors 
and radioactivity was measured in a liquid scintillation counter. 
Tryptic Phosphopeptide  Mapping of  EGF-R 
Aliquots of  the formic acid resuspended TCA pellets (see above) were dried 
in a Speed-Vac centrifuge (Savant,  Hicksville, NY).  Samples were subse- 
quently treated with performic acid and trypsin as described by Beemon and 
Hunter (1). Tryptic phosphopeptides were separated on thin layer cellulose 
plates (Merck 5716) by electrophoresis, at pH 8.9,  at  1,000 V  for 20 min 
in  the first dimension,  followed by  ascending chromatography in  n-bu- 
tanol/pyridine/acetic acid/HzO (75:50:15:60). 
Receptor Turnover 
Cells, grown to subconfluency on  12-well tissue culture clusters (Costar) 
were  labeled  for  16  h  with 40  I.tCi [35S]methionine  (Amersham,  1,350 
Ci/mmol sp act) per ml of methionine-free DME containing 0.5% FCS at 
t =  0. The labeling medium was replaced with DME/0.5% FCS containing 
500  I.tg/ml methionine. At different time intervals, cells were scraped in 
RIPA buffer and the receptor was precipitated with antiserum 281-7. The 
precipitates  were  applied  to  a  5-15%  linear  SDS-polyacrylamide  gel. 
Receptor was eluted from the gel after autoradiography as described under 
the previous heading. Radioactivity of the eluate was measured in a liquid 
scintillation counter. 
Results 
Reactivity of  Antibodies with A431 Antigens 
The properties of anti-EGF-R monoclonal antibodies TL-5- 
IgG3 and 29.1-IgG1 have been described in detail elsewhere 
(19, 32, 33). We have raised a number of EGF-R reactive an- 
tibodies ourselves  (10). Three  of these:  2E9-IgG1,  2Dll- 
IgG3 and 2G5-IgG2A have been used in the present study. 
Fig. 1 A shows that these antibodies precipitate autophospho- 
Figure 1.  EGF-R precipitation and glycolipid recognition by mono- 
clonal antibodies.  (A)  Autoradiograph of 32p-labeled immunopre- 
cipitates subjected to electrophoresis on SDS-PAGE. A431  plasma 
membrane  preparations  were  treated  with  EGF  and  [32P]y-ATP, 
solubilized and immunoprecipitated with the indicated antibodies 
(C  =  nonimmune  mouse  serum,  100x  diluted).  (B)  Immuno- 
peroxidase staining of glycolipid extracts of A431 cells separated on 
silicagel plates and treated with the indicated antibodies. The num- 
bers  on the  left side indicate  glycolipid standards GL2  and  GL4 
(two and  four sugar residues linked to ceramide respectively). 
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Antibodies 2Dll and 2G5 are, like TL-5 and 29.1 directed 
against blood group A-related carbohydrate determinants. 
These  antibodies  specifically haemagglutinate  A-antigen- 
bearing erythrocytes. Furthermore, they are unable to pre- 
cipitate biosynthetically labeled receptor from cells treated 
with tunicamycin. Antibody 2E9 does not haemagglutinate 
A-bearing erythrocytes and does recognize the unglycosyl- 
ated 130-kD form of the receptor from tunicamycin treated 
A431  cells (Defize, L.  H.  K., J.  Boonstra, and S.  W.  De 
Laat, manuscript in preparation). As was reported for other 
EGF-R antibodies reactive with carbohydrates (16, 20), the 
number of binding sites for 2Dll and 2G5 on A431 cells ex- 
ceeds the number of EGF-R by about one order of magnitude 
(not shown). Antibody TL-5 on the other hand, despite its 
blood group A  reactivity, was  reported to recognize only 
'~1.2  ×  106 antigenic sites on A431 cells (32). Several blood 
group A reactive anti-EGF-R antibodies have been reported 
to cross-react with glycolipids (16, 28). This has not yet been 
reported for TL-5 and 29.1.  Fig.  1 B shows  that 2Dll  and 
2G5, as well as 29.1 and also TL-5 indeed recognize a num- 
ber of complex glycolipids isolated  from A431  cells.  On 
the other hand  antibody 2E9 has no such cross-reactivity 
(Fig.  1 B). 
Immunofluorescence and Lectin Binding on A431 Cells 
Immunofluorescence studies revealed that in A431 cells 30- 
40%  of the cells were not recognized by any of the  four 
anti-carbohydrate antibodies (shown for 2Dll in Figs. 2, A 
and B). This phenomenon was not restricted to the particular 
clone used  in  our  laboratory  (obtained  from G.  Todaro, 
Oncogene, Seattle, WA) since we observed the same differ- 
ential labeling in A431  cells obtained from another source 
(J.  Schlessinger, Rehovot, Israel).  In contrast, fluorescein- 
ated EGF and antibody 2E9 labeled all cells with equal inten- 
sity (shown for 2E9 in Fig. 2, C and D). Thus, the nonreac- 
tivity of cells with 2Dll, 2G5, TL-5, and 29.1 was not due 
to low levels or absence of receptor, but reflected a variance 
in the carbohydrate structure of  the membrane. This variance 
was  not correlated with  the passage  number of the cells, 
since the two cell types coexisted over prolonged periods of 
culture time, without any apparent change in relative num- 
bers (up till 80 passages,  not shown). 
As reported earlier, antibody 2Dll mimics EGF in induc- 
ing rapid rounding up of A431 cells (10).  As shown in Fig. 
2, E and F, only the cells that are labeled by this antibody 
are rounded up, demonstrating that this effect is caused spe- 
cifically by the binding of 2Dll and in addition that there is 
no variation between the antibody-reactive cells with respect 
to this phenomenon.  EGF-induced morphological changes 
in all cells, eliminating a structural defect in the cytoskeleton 
of the unlabeled cells as a basis for their unresponsiveness 
to 2Dll. 
To learn more about the structural differences in mem- 
brane carbohydrates in the two cell types, a number of lectins 
were tested by double-labeling experiments together with the 
antibodies. Two lectins, Dolichos biflorus lectin (DBA) (an 
obligate exogalactosaminolectin [17])  and  Ulex europaeus 
lectin (UEA-1) (an obligate exofucolectin [17]), gave unam- 
biguous differential labeling of the two clones. Fluorescein- 
labeled derivatives of these lectins were added together with 
rhodamine-labeled antibody 2D11. As can be seen in Fig. 3, 
D-F, only those cells which are recognized by 2D11 are also 
heavily labeled by DBA. In contrast, only those cells which 
are not recognized by 2Dll bind UEA-1  (Fig.  3, A-C). 
These results suggested that the cells which do not bind 
blood group A reactive anti-EGFR monoclonal antibodies 
are  missing  the  terminal  N-acetyl galactosamine  residue. 
Such a truncation would result in a blood group H-like struc- 
ture, which has a terminal fucose residue, confirmed by the 
reactivity of the antibody/DBA negative cells with UEA lec- 
tin. Interestingly, Fredman et al.  (16) and Willingham and 
Pastan (40) reported differential staining of A431 cells with 
an anti-EGF-R monoclonal antibody directed against a blood 
group H-like structure. 
Cloning ofA431 Subtypes 
The A431  cells  were  subcloned by  limiting  dilution  (see 
Materials and Methods) and clones were screened for reac- 
tivity with  antibodies  2DI1,  2G5,  TI-5,  and  29.1.  Clones 
which reacted seemingly uniform (positively or negatively) 
with the antibodies were recloned. All clones positive for the 
antibodies also reacted uniformly with F1-DBA. Conversely, 
the negative cells were unable to bind F1-DBA,  but reacted 
uniformly with F1-UEA (not shown).  After several rounds 
of subcloning two particular clones, designated A431A  ÷ and 
A431A- respectively, were selected for further biochemical 
characterization. The differential A-antigen expression was 
a stable phenotypical trait for both clones and did not change 
even after prolonged periods of culture. 
Biochemical Characterization  of the Difference in 
Glycosylation Between the Clones 
The lectin-binding studies suggested that in surface carbohy- 
drates of A431A- cells only the terminal GalNAc residue is 
absent. Furthermore, there was no detectable difference in 
the molecular mass of EGF-R from the two clones (Fig. 5), 
excluding large truncations in receptor carbohydrates.  An 
important clue to the nature of the A431A- phenotype came 
from measurements of UDP-GalNAc:Gal transferase activ- 
ity in cell lysates of the clones. This enzyme converts A- 
carbohydrate structures into blood group A determinants by 
catalyzing an ~tl-3  glycosidic linkage of a GalNAc residue 
(34).  We quantitated UDP-GalNAc:Gal activity in cell ly- 
sates  by  measuring  incorporation  of  14C-labeled  UDP- 
GalNAc into A- porcine submaxillary mucine (PSM,  iso- 
lated from porcine submaxillary glands as described (34). 
The results of these measurements are given in Table I. The 
activity  of UDP-GalNAc:Gal  transferase  is  very high  in 
clone A431A ÷ as  compared with  clone A431A-,  strongly 
suggesting that the inactivity or absence of this enzyme in 
the latter cells constitutes the biochemical basis for their A- 
phenotype. 
Properties of EGF-R in A431A ÷  and A431A- Cells 
EGFBinding.  To determine whether the difference in recep- 
tor carbohydrate composition had any consequence for EGF- 
R  activity, we compared EGF-R properties in the clones. 
First, the number of receptors per cell and the kinetics of 
~25I-EGF binding  were determined.  Scatchard  analysis  of 
binding data (Fig. 4, left panel) revealed two receptor classes 
for each cell type, while the total amount of EGF-R was 
slightly higher in A431A- cells: 2.8  ×  106 receptors corn- 
The Journal of Cell Biology, Volume  107, 1988  942 Figure 2. Phase contrast and immunofluorescence images of A431 cells with anti-EGF-R monoclonal antibodies.  (A and B) 3% p-form- 
aldehyde fixed A431 cells were subsequently treated with monoclonal antibody 2DI1 and a goat anti-mouse-FITC conjugate. (,4) Phase- 
contrast  image, (B) fluorescent image of the same field; (C and D) as in A and B, but with monoclonal antibody 2E9;  (E and F) as in 
A and B but in unfixed cells at 37°C. Bar, 50 ~tM. 
pared with 2.3  x  106 receptors in A431A + cells.  The exis- 
tence of two affinity classes of receptors on A431  cells has 
been reported by others (20,  23, 30). High affinity receptors 
constitute only about 5 % of the total receptor pool, while the 
difference in dissociation constant between the two receptor 
classes is about one order of magnitude. Low abundance in 
combination with the  small difference in dissociation con- 
stant make it extremely difficult to quantitatively  measure 
high  affinity receptors  in  A431  cells by regular  Scatchard 
analysis, since this is done by extrapolation of the initial part 
of the graph to the X-axis. Small errors in this area therefore 
lead to large errors in the calculated number of receptors. As 
will be reported elsewhere (Defize, L.  H. K., J.  Boonstra, 
and S. W. De I.aat, manuscript in preparation), antibody 2E9 
Defize et al.  EGF-R Activity in GalNAc-deficient A431  Cells  943 Figure 3. Phase-contrast and fluorescence images of A431 cells double-labeled with lectins and antibody 2D11. (A-C) 3 % p-formaldehyde 
fixed A431 cells were treated simultaneously with antibody 2Dll  and  UEA lectin-FITC  complex and subsequently with goat anti- 
mouse-TRITC complex. (D-F) as in A-C,  but instead of UEA-FITC, DBA-FITC was used. (A and D) Phase-contrast images; (B and 
E) rhodamine fluorescence, (C and F) fluorescein fluorescence. Bar, 50 I.tM. 
blocks EGF binding to low affinity EGF-R in a variety of cell 
type  s, while leaving high affinity EGF binding unperturbed. 
To quantitate high affinity receptors in the clones, we prein- 
cubated cells with a saturating amount of  2E9 (300 nM), thus 
blocking low affinity sites completely. Fig. 4  (right panel) 
shows a  Scatchard analysis of EGF binding to these cells. 
Clearly, in both clones only a single, high affinity receptor 
class  (Kd 0.4  nM)  is  detected under  these  circumstances. 
Surprisingly however, the contribution of this subclass to the 
total receptor population is significantly higher in A431A- 
cells as compared with A431A + cells:  175,000 receptors per 
cell (6.3% of total) vs.  72,000 (3.2%  of total) respectively. 
Since high affinity EGF-R have been implicated by others 
to be the biologically active species with respect to signal 
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in  Cell Lysates 
Clone  Activity 
pmol/mg -I per h 
A431A ÷  267  ___  17  (n  =  3) 
A431A-  17  +  5  (n  =  3) 
Cell lysates were incubated with A-PSM (see text) and UDP-[~4C]GalNAc as 
described in Materials and Methods. GalNAc transferase activity is expressed 
in pmoles GalNAc  incorporated per milligram of cellular protein per hour. 
Values are corrected for background (no A-PSM  in the incubation mixture). 
transduction (23, 30), we next compared the EGF-R protein- 
tyrosine kinase activity in the clones. 
EGF-R Protein-l~erosine Kinase Activity in 
Membrane Preparations 
Receptor protein-tyrosine kinase activity was measured with 
[y32p]ATP as phosphate donor, either in total cell lysates or 
in plasma membrane preparations of the clones.  The auto- 
radiograms of total cell lysates prepared from equal amounts 
of cells are shown in Fig. 5 A. In clone A431A- the level of 
receptor phosphorylation both  with  and  without EGF  was 
higher than in clone A431A  +. Since this difference could be 
due to substrate competition, given the higher level of phos- 
phate incorporation into other proteins present in the cell ly- 
sate of A431A  + cells (notably a protein with a Mr of 94 kD) 
we repeated the experiments with plasma membrane prepa- 
rations from the clones. Also here, the difference in receptor 
autophosphorylation was apparent (Fig. 5 B). Receptor auto- 
phosphorylation with and without EGF, as well as the phos- 
phorylation  of  several  endogenous  proteins,  were  about 
threefold  higher  in  A431A- cells  as  measured  by densito- 
metric scanning of the autoradiogram depicted in Fig.  5 B. 
Importantly, the EGF-R content of the membrane prepara- 
tions (total number of receptors per milligram of protein), as 
checked by  EGF-binding  assays  (see  Materials  and  Meth- 
ods), was equal for both clones. The heavily labeled 94-kD 
protein in total cell lysates of A431A  ÷ cells (Fig.  5 A),  was 
found to a much lesser extent in the plasma membrane prepa- 
rations. Phosphoamino acid analysis showed that in these ex- 
Figure 5. Autoradiographs  of phosphorylated total cell lysates and 
membrane preparations  of A431A  + and  A431A- cells.  (A) Total 
cell lysates prepared from 28 cm  2 dishes as described in Materials 
and  Methods,  or (B)  plasma  membranes  prepared  according to 
Thom (39) were preincubated  with or without EGF for 10 min at 
20°C.  The phosphorylation reaction was  started  by adding  32p_ 
phosphorylation mix as described in Materials  and Methods. Phos- 
phorylation was for 10 min at 0°C (all lanes except lanes 3 and 6 
in B) or for 20 min at 0°C (lanes 3 and 6 in B). The samples were 
boiled  in Laemmli sample buffer and  separated  on linear 5-15% 
SDS-polyacrylamide gradient gels. 
periments  the  receptor  was phosphorylated  exclusively on 
tyrosine residues,  while tryptic phosphopeptide analysis re- 
vealed no differences in the sites of receptor autophosphory- 
lation (results  not shown). 
The differences in incorporation of radioactive phospho- 
rus could be the result of a difference in the activity of phos- 
phatases rather than of enhanced kinase activity. Therefore, 
the  time  dependent  32p  incorporation  into  the  total  TCA 
precipitable fraction from plasma membranes was measured 
in the presence or absence of EGE In a parallel experiment, 
excess cold ATP was added to the incubation mixtures to stop 
32p incorporation and test for possible phosphatase activity. 
The results of these experiments are depicted in Fig. 6. Clear- 
ly, no such activity was measurable in the membrane prepa- 
rations,  while the total 32p incorporation was again signifi- 
cantly higher over the total time course in A431A- plasma 
membranes. 
Finally,  phosphorylation of the tyrosine-containing pep- 
tide angiotensin I was measured in the absence or presence 
B  A 
O,4 
i  0'0 
BOUND  (  fmoU/105  cells) 
Figure  4.  Scatchard  analysis  of  [~25I]EGF binding  to  A431A  ÷ 
(squares) and A431A- (circles) cells,  either untreated  (A) or pre- 
treated  for 180 min at 20°C with 300 nM of antibody 2E9 to block 
low  affinity  EGF  binding  (B).  Cells  (density  50,000  celis/cm  2) 
were treated for 120 min at 0°C with [~2Sl]EGF (0.5 ng/ml) and in- 
creasing concentrations of unlabeled  EGE Cells were washed five 
times  with ice cold PBS,  taken  up in 0.5  M  NaOH and cell  as- 
sociated  radioactivity  was determined in a gamma counter. 
~15. 
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Figure 6. Incorporation of 32p into the TCA precipitable  fraction of 
A431A  ÷ and A431A- plasma membrane vesicles. A431A  + (squares) 
or A431A-  (circles) plasma  membrane  vesicles  (25  ~tg protein) 
were incubated  at 0°C with [32P]7-ATP  in the presence (open sym- 
bols) or absence (closed symbols) of EGE At t  =  15 (marked  by 
arrow) a 300-fold excess of unlabeled  ATP was added to some of 
the samples (dotted lines). Incorporation of 32p in the TCA pre- 
cipitable  fraction was  determined  as described  in  Materials  and 
Methods. 
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Figure  7.  Phosphorylation  of  an- 
giotensin  I by A431A  ÷ and A431A- 
plasma  membranes.  Plasma  mem- 
branes  (25  lag of protein)  were  in- 
cubated  with  [32p]y-ATP and  an- 
giotensin  I (20 mM) in the presence 
or absence of EGF as indicated.  In- 
corporation of 32p  into  the  peptide 
was  determined  as  described  in 
Materials  and  Methods. 
of EGF. As shown in Fig.  7, these experiments showed that 
also towards an exogeneous substrate,  the A431A- receptor 
has a  higher tyrosine kinase activity.  Whereas  the  relative 
stimulation by EGF is roughly the same in both preparations 
(9.6 times  the basal level),  the A431A- preparations  gave a 
1.6-fold higher  level  of phosphorus  incorporation  into  an- 
giotensin I. 
Measurements of  Receptor Activity in Intact Cells 
To measure the activity of the receptor in intact cells,  cells 
were  labeled  with  32p  for  18  h  and  subsequently  treated 
with EGF or buffer for a  further 30 rain.  After this period 
the cells were scraped and lysed in RIPA buffer (see Mate- 
rials and Methods)  and the receptor was precipitated.  In a 
parallel series of cells the total cellular phosphotyrosine con- 
tent was measured without receptor precipitation.  The out- 
come of these experiments,  as shown in Fig. 8 and Table II, 
confirmed the results  from the previous experiments.  Both 
the  relative  cellular  phosphotyrosine  content  (Table  II) as 
well as  the absolute amount of phosphotyrosine present  in 
the precipitated receptor (Fig. 8 B) were significantly higher 
in unstimulated  as well as in EGF-stimulated A431A- cells 
than in A431A  + cells.  Interestingly, quantitative  determina- 
tion of the relative amounts of receptor phosphoaminoacids 
revealed  no differences  between  the  clones (Table  II).  Ac- 
cordingly, tryptic phosphopeptide  maps of the precipitated 
receptor  were  identical  (Fig.  8  C),  also  confirming  that 
there are no major structural EGF-R differences between the 
clones. 
The results  presented  thus  far indicate  that:  (a)  A431A- 
cells display an elevated level of protein-tyrosine kinase ac- 
tivity.  Given the results of the in vitro experiments,  this  is 
Figure 8. EGF-R phosphorylation in intact cells. 32p labeled A431A+/A431A  - cells were treated for 30 min with EGF (50 ng/ml) or buffer, 
iysed in RIPA buffer, and the EGF-R was immunoprecipitated  as described in Materials and Methods.  The immunoprecipitates  were applied 
to linear 5-15% SDS-polyacrylamide gels.  (A) Autoradiograph of EGF-R bands in the dried gel.  Receptor bands were cut out from the 
dried gel,  the receptor protein was eluted and (B) subjected  to phosphoamino acid analysis  and (C) tryptic phosphopeptide mapping as 
described in Materials  and Methods.  For autoradiography,  preflashed Kodak XAR5 films were used in combination with Kodak X-Omatic 
regular intensifying  screens,  cpms Loaded were from left to right:  (B) 400 cpm; 1,100 cpm; 600 cpm; 1,400 cpm, (C) 2,250 cpm; 5,000 
cpm; 3,100 cpm; 7,300 cpm. Exposure was for 24 h at  -70°C. 
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A431A  ÷  A431A 
Total cellular protein  -EGF  +EGF  -EGF  +EGF 
EGF-R 
P-SER  92.04  92.33  92.33  92.61 
P-THR  7.94  7.62  7.65  7.30 
P-TYR  0.015  0.060  0.035  0.090 
cpm total  24,656  59,427  39,569  72,188 
P-SER  58.59  52.43  66.07  59.43 
P-THR  37.17  28.56  29.53  20.76 
P-TYR  4.23  19.00  4.40  19.81 
For total cellular phosphoamino  acid (PAA)  analysis, lysates from 32P-labeled A431 cells were treated as described in Materials and Methods. From parallel se- 
ries of lysates, the EGF-R was immunoprecipitated, subjected to SDS-gel electrophoresis, and analyzed for PAA content. The PAAs were separated by two- 
dimensional high-voltage  thin layer  electrophoresis as described in Materials and Methods. The radioactivity  in the PAA spots was determined by liquid scintillation 
counting as described in Materials and Methods. Numbers represent the radioactivity  present in individual PAAs  as the percentage of radioactivity  present in the 
three PAAs  together. For the immunoprecipitated receptor the number of cpm's in the gel band as measured by Cerenkov radiation are also indicated. 
most probably attributable to the EGF-receptor in these cells, 
(b) in A431A- cells there is no increase in the relative amount 
of phosphotyrosine present in the EGF-R as compared with 
A431A  + cells,  which indicates  that the elevated level of ty- 
rosine autophosphorylation of the receptor in A431A- cells 
is  accompanied  by  an  increase  in  phosphorylation  of the 
receptor on serine and threonine residues, probably by other 
cellular kinases.  Such phosphorylations could play a regula- 
tory role in receptor functioning,  for instance by providing 
(a)  signal(s)  for receptor internalization  and breakdown. 
Receptor Turnover in A431 ÷  and A431A- Cells 
The turnover of EGF-R is increased considerably after acti- 
vation by EGF (38). If there is a direct relationship between 
receptor tyrosine kinase activity and receptor breakdown as 
recently suggested by Honegger et al.  (21),  the turnover of 
EGF-R protein should be faster in A431A- cells.  To deter- 
mine the half-life of the receptor in the clones,  we labeled 
cells metabolically with [35S]methionine for 16 h. After this 
the cells were chased with excess cold methionine, the recep- 
tor was isolated from the cells at various time intervals,  and 
its radioactive  content measured  as described  in Materials 
and Methods  and the legend Fig.  9. While the turnover of 
[35S]methionine  in  total  cell  protein  was  essentially  the 
same  (not shown),  the half life of the  receptor  in A431A- 
cells was significantly shorter:  '~10 h vs.  '~17.5 h in A431A  + 
cells  (Fig.  9).  Under  identical  experimental  conditions  the 
half-life of the receptor in uncloned A431 cells was 14 h (not 
shown). 
Discussion 
In the present  study,  we report that the human epidermoid 
carcinoma cell line A431 consists of at least two different cell 
types which'differ in carbohydrate composition of the EGF-R 
and other plasma membrane constituents.  These cell types 
coexist for a prolonged period of tissue culture without any 
apparent change in relative numbers.  Furthermore,  we re- 
port that stable clones of each cell type can be obtained from 
the  parental  cells,  showing  that  the  observed  differential 
labeling of the uncloned cells is not due to some cell cycle 
phenomenon as was suggested by others who reported simi- 
lar observations  (5,  40). 
The  EGF-  and  2E9-binding  data  indicate  that  the  total 
number of receptors is roughly equal for both clones. Thus, 
the  differential  reactivity  of blood  group A  reactive  anti- 
EGF-R antibodies toward these lines is not due to a differ- 
ence in receptor expression.  The lectin-binding data and the 
measurements of UDPGalNAc:Gal transferase activity indi- 
cate that A431A- cells differ from A431A  ÷ cells in that Gal- 
NAc residues  are absent from carbohydrates in the former 
cells.  Interestingly,  Willingham  and  Pastan  (40)  showed 
differential reactivity of A431 cells with an antibody (MC101) 
directed against a blood group H-like antigen, which can be 
derived from the A-antigen by removal of the terminal Gal- 
NAc residue.  This antibody thus probably only recognizes 
A431A- cells. Our data of course do rule out the possibility 
of other deletions or substitutions  in carbohydrate residues 
in A431A- cells.  The  fact that the  molecular  mass  of the 
receptor in the clones is essentially the same however argues 
against  large deletions.  The complete unreactivity of anti- 
blood group A EGF-R antibodies with one clone shows that 
Figure 9.  EGF-R degradation in A431A  + and A431A- cells.  Cells 
were labeled  for 16 h with [35S]methionine. Labeling medium was 
replaced by fresh medium containing 300 mM methionine.  At vari- 
ous time points  up till  10 h after the medium change, cells  were 
lysed, the EGF-R was immunoprecipitated  and the precipitate  was 
subjected  to SDS-PAGE.  After autoradiography,  receptor bands 
were cut out from the gel and their radioactive  content was deter- 
mined as described in Materials  and Methods.  (e) A431A  ÷ cells; 
(zx) A431A-  cells.  (Inset)  Autoradiograph of  170-kD  region  of 
polyacrylamide gel.  Time of cell lysis from left to right: 0, 2.5,  5, 
7.5, and  10 h after medium change. 
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glycolipids as  substrates  since these  antibodies  recognize 
both types of molecules (16, 28,  Fig.  1). We do not know 
whether the glycosylation variants were already present in 
the tumor from which the A431  cell line was derived, or 
whether the appearance of the variants occurred spontane- 
ously at some later time point, nor do we have any clue about 
the  genetic  background  of the  variation.  Clones  A431A ÷ 
and  A431A-  both  have  an  aneuploid  karyotype in  which 
all human chromosomes are present, and both clones con- 
tain the chromosome 7 translocation typical for A431  cells 
(Geurts van Kessel, A., personal communication). 
Since our results show that A431 cells are inhomogeneous 
with respect to at least one structural feature of their EGF-R 
and given the fact that these cells are widely used as a model 
system to  study EGF-EGF-R interactions,  we decided to 
compare functional EGF-R properties in the clones. A possi- 
ble role for carbohydrates in receptor regulation has been 
reported by others. Podskalny et al. (29) have studied insulin 
receptor function in two Chinese hamster ovary (CHO) cell 
variants, and reported that the defects in carbohydrate pro- 
cessing in these cells lead, interestingly, to either a large in- 
crease or a  decrease in  the receptors' affinity for insulin. 
Kingsley et al. (25), also using CHO glycosylation mutants, 
showed that impaired carbohydrate processing leads to a di- 
minished low density lipoprotein (LDL) receptor stability. 
To our knowledge, the present study is the first to deal with 
EGF-R function in glycosylation variants. The fact that the 
differences in EGF-R functioning between the clones were 
found, as will be discussed below, of course does not provide 
a direct proof for a regulatory role of receptor carbohydrates. 
Other phenotypic parameters, not detected by our screening 
methods, could equally well be responsible for the observed 
phenomena. To obtain such a proof would require a rigorous 
statistical analysis of quite a number of clones. Experiments 
in which the enzyme N-Acetyl-galactosaminidase was used 
to remove the  A-antigen  and  look for possible  effects on 
receptor function failed, since the optimal conditions for this 
enzyme to work proved devastating to EGF-R stability (data 
not shown). 
The finding that in A431A- cells as compared with A431A  ÷ 
cells, a higher percentage of EGF-R is of a high affinity sub- 
class was  rather unexpected. Total absence of receptor gly- 
cosylation has a debilitating effect on its function (37).  How 
the absence of one sugar residue could lead to a shift in the 
distribution of high and low affinity sites might be explained 
by a model presented by Childs et al. (5) and Feizi and Childs 
(15). These authors suggest that interactions between carbo- 
hydrate determinants shared by glycoproteins and glycolip- 
ids,  for instance mediated by endogenous lectin-like mole- 
cules, play a regulatory role. In A431  cells, the A-antigen 
could perform such a  function, while in other cell types, 
which do not express the A antigen different carbohydrates 
and  lectins  might  be  involved.  Absence  of A-antigen  in 
A431A-  cells  could  lead  to an  altered  mobility and/or a 
change in the conformation of EGF receptors. This in turn 
could lead to an enhanced ability of receptors to aggregate, 
resulting in a shift in the high vs. low affinity equilibrium. 
Evidence for allosteric EGF-R activation by aggregation has 
recently been presented by Yarden and Schlessinger (41, 42). 
Based upon experiments with purified EGF-R preparations, 
these authors also propose that the high affinity, aggregated 
receptor population has  enhanced  protein-tyrosine kinase 
activity even without EGF (41). Fanger et al. (14) have also 
presented evidence that tyrosine kinase activity is primarily 
associated with high affinity EGF-receptors in Hela cells. In 
accordance with this, our results clearly demonstrate a paral- 
lel increase in high  affinity receptor number and protein- 
tyrosine kinase activity, both in membrane preparations as 
well as in intact cells. 
The role of EGF-R tyrosine (auto)phosphorylation in the 
cascade of events following EGF binding still  remains ob- 
scure. Recently, Honegger et al. (21) found that a point muta- 
tion at the ATP-binding site of the EGF-R which abolishes 
its tyrosine kinase activity, prevents receptor break down. 
These authors suggest that tyrosine (auto)phosphorylation 
provides a signal for receptor degradation, whereas unphos- 
phorylated receptors are  continually recycled back to the 
plasma membrane. In line with this, Chen et al. (4) reported 
that receptor protein- tyrosine kinase activity is required for 
the  induction  of EGF-R down  regulation by EGE  While 
these results demonstrate that absence of protein-tyrosine 
kinase activity prevents receptor breakdown, our results in- 
dicate that an elevated receptor (auto)phosphorylation is as- 
sociated with enhanced receptor breakdown. Even in A431A- 
cells, high affinity EGF-R comprise only a small fraction of 
the total receptor population. The increased turnover of the 
total receptor pool could be explained by (a) "cross"-phos- 
phorylation of low affinity EGF-R by high affinity receptors, 
or (b) continuous replacement of internalized high affinity 
receptors by new receptors recruited from the low affinity 
pool. At present, we cannot distinguish between these two 
possibilities. 
An effect of EGF is increased biosynthesis of its own re- 
ceptor (6). Since the total number of receptors is equally high 
in both clones, receptor biosynthesis must be increased in 
A431A- cells.  That indeed this is the case can be inferred 
from the higher amount of radioactivity present in the recep- 
tor from [35S]methionine-labeled cells (see Fig. 9, inset). 
The elevated tyrosine autophosphorylation of EGF-R in 
A431A- cells is accompanied by a parallel increase in ser- 
ine and threonine receptor phosphorylations, most probably 
by other protein kinases. Whether these additional modifica- 
tions play a role in the elevated activity of A431A- EGF-R 
or are simply a consequence of the increased receptor turn- 
over remains  to be established.  A431A  ÷ variants  with al- 
tered responses to EGF have been isolated by Buss et al. (2). 
In these cells, which have a decreased number of EGF-R, 
receptor kinase activation by EGF is decreased in compari- 
son with "wild-type" A431 cells, an effect which is correlated 
with absence of growth inhibition by EGF in these mutants. 
In our clones, receptor kinase activity is equally well stimu- 
lated by EGF,  while EGF inhibits growth of A431A  ÷ and 
A431A-  cells  to  a  similar  extent  (unpublished  observa- 
tions). 
In conclusion, our results demonstrate the existene of a 
substantial  amount  (40%)  of stable  glycosylation variants 
within the A431  cell line, which in its uncloned form is by 
far  the  most  extensively used  system to  measure  EGF-R 
functioning.  The isolation of these variants enabled us  to 
show that the difference is caused by the absence or presence 
of UDPGalNAc:Gal transferase activity, leading to absence 
of blood group A antigens on the EGF-R as well as on other 
glycoproteins  and  glycolipids  in  one  variant  (A431A-), 
while these antigens  are fully expressed in another (A431A÷). 
Furthermore we report a substantial difference in EGF-R ac- 
The Journal of Cell Biology, Volume  107, 1988  948 tivity  between  these  clones:  the  absence  of A-antigen  in 
A431A-  cells  is  correlated  with an elevated  ratio  of high 
over low affinity  EGF-R. We have discussed this phenome- 
non  in the  context of recent ideas  about receptor affinity 
regulation. Since the relative increase in high affinity EGF-R 
number in A431A- cells is paralleled by both an increase in 
receptor protein-tyrosine kinase activity as well as receptor 
turnover,  our  results  support  the  notion that  high  affinity 
receptors are the biologically active species with respect to 
EGF signal transduction. 
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